Cardio Diagnostics Holdings Inc
CDIO0.185USD
-0.027-12.85%
Fechamento 05/09, 16:00（ET）Cotações atrasadas em 15 min
8.50MValor de mercado
PerdaP/L TTM
Mais detalhes de Cardio Diagnostics Holdings Inc Empresa
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Informações da empresa
Código da empresaCDIO
Nome da EmpresaCardio Diagnostics Holdings Inc
Data de listagemNov 23, 2021
Fundado em2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Número de funcionários13
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 23
Endereço311 W. Superior Street
CidadeCHICAGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal60645
Telefone18552269991
Site
Código da empresaCDIO
Data de listagemNov 23, 2021
Fundado em2021
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
128.34K
-34.95%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.05K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
97.40K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
71.60K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
128.34K
-34.95%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.05K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
97.40K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
71.60K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: sex, 9 de mai
Tempo de atualização: sex, 9 de mai
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.70%
Millennium Management LLC
0.49%
Other
90.55%
Estatísticas dos acionistas
Acionista
Proporção
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.70%
Millennium Management LLC
0.49%
Other
90.55%
Tipo
Acionista
Proporção
Individual Investor
4.22%
Corporation
3.04%
Investment Advisor
2.69%
Investment Advisor/Hedge Fund
1.36%
Hedge Fund
0.62%
Research Firm
0.22%
Venture Capital
0.11%
Other
87.74%
Participação acionária institucional
Tempo de atualização: seg, 3 de mar
Tempo de atualização: seg, 3 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
43
6.55M
12.55%
+595.10K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
2023Q1
59
3.90M
40.53%
-6.83M
2022Q4
55
3.79M
39.83%
-7.64M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dogan (Meeshanthini)
1.66M
3.17%
--
--
Mar 20, 2025
Bd Holding, Inc
1.59M
3.04%
--
--
Mar 20, 2025
BlackRock Institutional Trust Company, N.A.
1.07M
2.05%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
364.39K
0.7%
+179.98K
+97.60%
Dec 31, 2024
Millennium Management LLC
256.94K
0.49%
+256.94K
--
Dec 31, 2024
The Vanguard Group, Inc.
232.14K
0.45%
--
--
Dec 31, 2024
HRT Financial LP
155.39K
0.3%
+144.38K
+1.31K%
Dec 31, 2024
Dogan (Timur)
128.34K
0.25%
-68.97K
-34.95%
Mar 20, 2025
Hosseinion (Warren)
116.05K
0.22%
--
--
Mar 20, 2025
Jane Street Capital, L.L.C.
112.56K
0.22%
+112.56K
--
Dec 31, 2024
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados